Treatment of Paget's Disease of Bone

ResearchSpace/Manakin Repository

Show simple item record

dc.contributor.author Reid, Ian en
dc.contributor.editor Reddy, SV en
dc.date.accessioned 2016-10-07T01:20:48Z en
dc.date.issued 2016 en
dc.identifier.citation In S. V. Reddy (Ed.), 2016, Advances in Pathobiology and Management of Paget's Disease of Bone (pp. 119-136). Elsevier / Academic Press, London. en
dc.identifier.isbn 012809690X en
dc.identifier.isbn 9780128096901 en
dc.identifier.uri http://hdl.handle.net/2292/30654 en
dc.description.abstract Paget's disease involves overactivity of both osteoblasts and osteoclasts within affected bone tissue. It is unclear in which cells the causative lesion resides, but therapies have generally been antiosteoclastic (antiresorptive) because these are the only pharmaceuticals that have been available. There is tight coupling between osteoblasts and osteoclasts, so antiresorptive therapies lead to decreases in osteoclast activity within days, followed by similar declines in osteoblast activity after a period of 2-3 months. The most commonly used test for monitoring disease activity is serum total alkaline phosphatase, which is a measure of osteoblast activity, though serum procollagen type I N-terminal propeptide is more bone-specific. The treatment of Paget's disease is now virtually always with a potent bisphosphonate, typically intravenous zoledronate since this has the highest rates of biochemical response and the greatest response longevity. en
dc.publisher Elsevier / Academic Press en
dc.relation.ispartof Advances in Pathobiology and Management of Paget's Disease of Bone en
dc.rights Items in ResearchSpace are protected by copyright, with all rights reserved, unless otherwise indicated. Previously published items are made available in accordance with the copyright policy of the publisher. en
dc.rights.uri https://researchspace.auckland.ac.nz/docs/uoa-docs/rights.htm en
dc.title Treatment of Paget's Disease of Bone en
dc.type Book Item en
dc.identifier.doi 10.1016/B978-0-12-805083-5.00009-9 en
pubs.begin-page 119 en
pubs.author-url http://www.sciencedirect.com/science/article/pii/B9780128050835000099 en
pubs.end-page 136 en
pubs.place-of-publication London en
pubs.publication-status Published en
dc.rights.accessrights http://purl.org/eprint/accessRights/RestrictedAccess en
pubs.elements-id 539233 en
pubs.org-id Medical and Health Sciences en
pubs.org-id School of Medicine en
pubs.org-id Medicine Department en
pubs.org-id Science en
pubs.org-id Science Research en
pubs.org-id Maurice Wilkins Centre (2010-2014) en
pubs.number 9 en
pubs.record-created-at-source-date 2016-10-07 en


Full text options

Find Full text

This item appears in the following Collection(s)

Show simple item record

Share

Search ResearchSpace


Advanced Search

Browse